ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
37.05
-2.09%
US Tech 100
18,112.40
-2.83%
S&P 500
5,306.63
-2.75%
US Dollar vs CAD
1.40257
-0.56%
Bitcoin
81,389.63
-1.45%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) News

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTC
DateTimeSourceHeadlineSymbolCompany
03/28/20254:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
03/27/20254:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
03/26/20259:53AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
03/26/20257:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
03/20/20254:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
03/19/20256:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
03/19/20256:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
02/14/20257:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
02/14/20256:51AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
01/03/20254:39PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/31/20245:34AMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
12/13/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
12/11/20245:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/11/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/11/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/10/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
12/06/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
11/14/20243:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
11/14/20243:35PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
11/14/20243:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
11/14/20243:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
11/12/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
11/01/20244:04PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
10/23/20248:23AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
10/22/20244:24PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
10/15/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
10/15/20245:08AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
10/11/20244:13PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
10/11/20243:53PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
10/11/20243:52PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

Your Recent History

LSE
GC76
Morg.st.b.v 26
LSE
DWHA
Dewhurst
LSE
46DR
Perm Mast B 42
BIT
P23013
Bnp Paribas Issuance
USOTC
SMME
SmartMetric (CE)
COIN
DHTUSD
dHEDGE DAO
NASDAQ
CHEA
Chenghe Acquisition
TG
51C
Chr Hansen
LSE
51EI
Investec Bnk 24
BIT
S29790
Societe Generale Effekten
NASDAQ
EQRR
ProShares Equities for R...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads